Use of an innovative short-term immunotherapy in daily practice: results from a post marketing surveillance study (PMS)
|
|
- Lee Fisher
- 5 years ago
- Views:
Transcription
1 Use of an innovative short-term immunotherapy in daily practice: results from a post marketing surveillance study (PMS) Dr.Albert Roger Reig Allergy Unit. H.U. Germans Trias i Pujol Badalona (Spain) Pollinex Quattro Allergoid containig MPL Th1 driving adjuvant 4 injections / weekly (up to 7) Pharmacoeconomic advantages Efficacy / tolerability Demonstrated in DBPC studies 1
2 Controlled and uncontrolled clinical trials: assessing real world significance in allergy What we really want to know, is how a certain drug would help our patients in a real world setting or everyday practice Thus, what we need are real world studies, often referred to as uncontrolled studies, to complete the full clinical picture of a drug Uncontrolled studies are often performed as post-marketing surveillance studies (PMS) Bachert C. AAAAI 2004 Pollinex Quattro PMS Spain Pollen respiratory allergy Under normal clinical practice conditions (open, observational) 2
3 Aim of study: Efficacy & Tolerability Efficacy (1) Antiallergic medication intake during the pollen season... Regular Frequent Occasional No medication... compared to the previous year before starting the treatment 3
4 Efficacy (2) Therapy success Very good / moderate improvement Slight improvement No change Worsened Assessed Physician Patient Tolerability - Adverse events - Acceptance of therapy by patients - Very good / good - Less good -Bad 4
5 3 years: 2001 (1) / 2002 (2) / visits / year Start immunotherapy End immunotherapy, before pollen season (tolerability assessment) Endpollenseason(efficacyassessment) (1) A.Roger. Pollinex Quattro: primeras experiencias en España. Alergol Inmunol Clin 2002; 17(suppl2):189. (2) A.Roger. Pollinex Quattro: eficacia y seguridad en alergia respiratoria. Alergol Inmunol Clin 2004; 19(suppl2):347. Patients Total = 483 Mean age = 30 (minimum 7) Diagnosis: 100% rhinitis 79% conjunctivitis 49% asthma 5
6 Prick test 74% grass pollens 53% olive 13% parietaria Grass pollen 6
7 Olive pollen Parietaria pollen 7
8 Immunotherapy Length of treatment One year = 73% Two / three years = 27% Schedule Four doses = 48% Four / seven doses = 92% Top dose = 2000 SU Grass = 20.8 mcgr major allergen Results (patients) Tolerability = 458 Efficacy = 452 8
9 Therapy success Antiallergic medication 9
10 Tolerability - Ease of administration (physician) - very good / good = 98% - Acceptance of therapy (patients) Acceptance of therapy by age 10
11 Adverse events Reaction None Local (1) Systemic (3) Patients Percentage (2) 0.4 (1) redness/swelling <10 cm (no treatment) (2) first year 4.3%; consecutive 1.2% (3) general itching; rhinitis/urticaria No anaphylactic reactions Local reactions by age 11
12 Length Immunotherapy: 1 versus 2-3 years Trend towards continuous improvement Medication intake Efficacy assessment Tolerability Occasional / No medication 1 year = 61% 3 years = 68% (p<0.0001) (p=0.0537) 12
13 Length / Efficacy Patient assessment Length / Efficacy Physician assessment 13
14 Length / Tolerability Acceptance by patients Length / Tolerability Acceptance: patients vaccinated 2-3 years 14
15 Pollinex PMS: Discussion Spain / Germany (EAACI 2004) Improvement (patient) = 92% / 93% Antiallergic medication % Regular Occasional Before 34 / /16 After 10 / 8 49 / 52 Pollinex PMS: Discussion Spain / Germany (EAACI 2004) Acceptance of therapy (patient) very good / good = 92% / 93% Local reactions (years) First Last 4% 1% 8% 2% Grasses / Olive / Parietaria Grasses / Birch / Alder / Hazel 15
16 Summary Respiratory allergic adults and children Under normal clinical practice conditions Effective on assessment by both physicians / patients Antiallergic medication use decrease Good tolerability profile Spanish 3-year Pollinex PMS Conclusion Confirmed our encouraging results from the first and second year of therapy Endorses the success of previous DBPC studies High efficacy Good tolerability 16
Allergen immunotherapy: from EBM to doctors and patients need
Allergen immunotherapy: from EBM to doctors and patients need Moscow, Marriott Hotel February 28th, 2019 Dr. Franco Frati Medical Department Milan, Italy From the recognition of the pollen to in vivo tests
More informatione. Elm Correct Question 2 Which preservative/adjuvant has the greatest potential to breakdown immunotherapy because of protease activity? a.
Allergen Immunotherapy Practical Quiz Question 1 Which of the following pollens shows cross-reactivity with birch pollen? a. Alder b. Olive c. Ash d. Black walnut e. Elm Question 2 Which preservative/adjuvant
More informationThree-year Short-term Specific Immunotherapy (SIT): A Multi-centre, Double-blind Placebo-controlled Study with L-tyrosine adsorbed Pollen Allergoids
Three-year Short-term Specific Immunotherapy (SIT): A Multi-centre, Double-blind Placebo-controlled Study with L-tyrosine adsorbed Pollen Allergoids Introduction KJ Drachenberg, U Feeser, and P Pfeiffer
More informationimmunotherapy to parietaria. A controlled field study
O R I G I N A L A R T I C L E Eur Ann Allergy Clin Immunol VOL 42, N 3, 115-119, 2010 A. Musarra 1, D. Bignardi 2, C. Troise 2, G. Passalacqua 3 Long-lasting effect of a monophosphoryl lipidadjuvanted
More informationSUMMARY OF PRODUCT CHARACTERISTICS. POLLINEX Trees Extension Course, 2000 Standardised Units (SU)/0.5ml, suspension for injection
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT POLLINEX Trees Extension Course, 2000 Standardised Units (SU)/0.5ml, suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationSUMMARY OF PRODUCT CHARACTERISTICS. POLLINEX Trees, 300, 800 and 2000 Standardised Units (SU)/0.5ml, suspension for injection
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT POLLINEX Trees, 300, 800 and 2000 Standardised Units (SU)/0.5ml, suspension for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION POLLINEX
More informationRECOMMENDATIONS FOR APPROPRIATE SLIT TRIALS
RECOMMENDATIONS FOR APPROPRIATE SLIT TRIALS Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal MedicineIRCCS S.Martino IST University of Genoa ITALY CHICAGO-WAO-2013 ISHIZAKA NOON UK CSM
More informationAllergy Therapeutics. Corporate Presentation. Proactive Investors 28th January 2016 Ian Postlethwaite, Finance Director
Allergy Therapeutics Corporate Presentation January 2016 Introduction We treat people with Allergic disorders Focused on the moderate to severe patients Providing treatments that cure the disease, not
More informationAssessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy
Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy Tolly Epstein, MD, MS Assistant Professor of Clinical Medicine Division of Immunology, Allergy & Rheumatology University
More informationTREATING ALLERGIC RHINITIS
TREATING ALLERGIC RHINITIS Prof. Dr. Jean-Baptiste Watelet, MD Department of Otorhinolaryngology Ghent University Hospital Ghent, Belgium Allergic rhinitis (AR) is a nasal disease with the presence of
More informationDoes hay fever affect your quality of life? Immunotherapy may be the answer
Does hay fever affect your quality of life? Immunotherapy may be the answer If your hay fever (allergic rhinitis) is causing you misery, and you re not seeing improvements in your symptoms despite trying
More informationThe Polli Concept. Highly effective against hay fever and allergies. For further information:
The Polli Concept Highly effective against hay fever and allergies. For further information: www.polli-allergie.de/en Polli the allergy concept. Your highly effective protection against hay fever and allergies.
More informationImmunotherapy. Chris Doyle Consultant Nurse Respiratory & Allergy Alder Hey Childrens NHS FT. October 18 th 2014
Immunotherapy Chris Doyle Consultant Nurse Respiratory & Allergy Alder Hey Childrens NHS FT Chris.doyle@alderhey.nhs.uk October 18 th 2014 What exactly is Immunotherapy? Medical procedure that uses controlled
More informationOpinion 8 January 2014
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 8 January 2014 WYSTAMM 1 mg/ml, oral solution 120 ml vial with syringe for oral administration (CIP: 34009 222 560
More informationWhat are Allergy shots / SCIT?
Allergy diagnosis must be made accurately with correct history and tests including the skin prick test and the blood test like immunocap / Phadiatop study. This once made will help decide the dose and
More informationDefinition of Allergens 2013 Is there a need for Seasonal & Perennial?
MANIFESTO Definition of Allergens 2013 Is there a need for Seasonal & Perennial? Canonica G.W. Baena Cagnani C.E. Bousquet J. Pawankar R. Zuberbier T. Reasons for NOT using the classification of SEASONAL
More informationClinical Study Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration Schedule Method Using Purethal Trees
BioMed Research International, Article ID 707634, 5 pages http://dx.doi.org/10.1155/2014/707634 Clinical Study Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration
More informationappropriate olive pollen SIT
OLIVE POLLEN Molecular Allergology Use components to identify patients for appropriate olive pollen SIT Resolve multiple positivity to pollen tests Use components to resolve multiple positivity to pollen
More informationEconomic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany Schadlich P K, Brecht J G
Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany Schadlich P K, Brecht J G Record Status This is a critical abstract of an economic evaluation
More informationPollen immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis (The PAT-Study)
Pollen immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis (The PAT-Study) Christian Möller 1, Sten Dreborg 2, Hosne A. Ferdousi 3, Susanne Halken 4, Arne Høst
More informationUse of SLIT in allergy practice: Is it ready for prime time? Stanley Fineman, MD, MBA Atlanta Allergy & Asthma Clinic AAIFNC, Feb 7, 2015
Use of SLIT in allergy practice: Is it ready for prime time? Stanley Fineman, MD, MBA Atlanta Allergy & Asthma Clinic AAIFNC, Feb 7, 2015 Disclosures Speakers bureau/consultant: AZ, Genentech/Novartis,
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More informationCharacteristics of allergy in autoimmune thyroid diseases. Ildikó Molnár MD, PhD, EndoMed, Hungary
Characteristics of allergy in autoimmune thyroid diseases Ildikó Molnár MD, PhD, EndoMed, Hungary Relationship between allergic responses and thyroid autoimmunity IgE levels IgE deposits are present in
More informationWe improve quality of life by preventing and curing allergy
We improve quality of life by preventing and curing allergy SEB Enskilda Nordic Small & Mid Cap Seminar 2008 Jens Bager, President & CEO ALK-Abelló a fast growing pharmaceutical company Global pharmaceutical
More informationNew Approaches to Immunotherapy
New Approaches to Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health and University of Colorado School of Medicine, Denver, Colorado, USA Faculty Disclosure Harold S. Nelson,
More informationExpert Roundtable on Sublingual Immunotherapy
Expert Roundtable on Sublingual Immunotherapy FACULTY Linda Cox, MD Clinical Associate Professor, Nova Southeastern University Thomas Casale, MD Professor of Medicine, University of South Florida Peter
More informationNew Medicine Report (Adopted by the CCG until review and further
New Medicine Report (Adopted by the CCG until review and further GRASS ALLERGEN TREATMENT notice) Document Status Decision following Suffolk D&TC meeting Traffic Light Decision Red for 2007 with review
More informationINVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim
INVESTIGATIONS & PROCEDURES IN PULMONOLOGY Immunotherapy in Asthma Dr. Zia Hashim Definition Involves Administration of gradually increasing quantities of specific allergens to patients with IgE-mediated
More informationCenters. Austria (2), Germany (5), Belgium (1), Netherlands (1), Denmark (1), Slovenia (1)
Study CS-BM32-003 Sponsor Biomay Protocol title Phase IIb study on the safety and efficacy of BM32, a recombinant hypoallergenic vaccine for immunotherapy of grass pollen allergy Clinical trial phase Phase
More informationPollen and clinical report in France
Pollen and clinical report in France INTRODUCTION Prevalence of respiratory allergies (allergic rhinitis or asthma) in France affects between 20% and 30% of the population. The RNSA (Réseau National de
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 GRAZAX 75 000 SQ-T, oral lyophilisate B/30 (CIP: 378 011-6) B/100 (CIP code: 378 012-2) B/90 (CIP code:
More information(26000)=I
Table E1. Literature search Search Cochrane Databases of Systematic Reviews, Database of Abstracts of Reviews of Effectiveness, and Central; Literature search 2015, April 25 th 1. "asthmazoekacties jan
More informationDelivering on our strategy
Delivering on our strategy Preliminary Results for the year end 30 June 2018 Manuel Llobet, Chief Executive Officer Nick Wykeman, Chief Financial Officer Disclaimer The information contained in this presentation
More informationMore than half to 50 million 5th 3rd
Did you know? More than half (54.6%) of all U.S. citizens test positive to one or more allergens. Allergic diseases affect as many as 40 to 50 million Americans, including asthma and bronchitis. Allergies
More informationWhich Factors Might Enhance Safety of Immunotherapy in Your Clinic?
Which Factors Might Enhance Safety of Immunotherapy in Your Clinic? David I. Bernstein MD FAAAI Professor of Medicine and Environmental Health Division of Immunology and Allergy University of Cincinnati
More informationALK-Abelló A/S. Click View,Header and Footer to change this text to filename and department name
ALK-Abelló A/S June 25, 2008 Click View,Header and Footer to change this text to filename and department name 1 Changing the way we treat allergy Piper Jaffray 19th Annual Health Care Conference, New York
More informationThe RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT
Original article The RHINASTHMA GAV scores without SLIT, at the beginning and at the end of seasonal SLIT Jochen Sieber, 1 Anna Gross, 2 Kija Shah-Hosseini 2 and Ralph Mösges 2 Summary Background: The
More informationSecondary prevention of allergic disease. Dr Adam Fox United Kingdom
Secondary prevention of allergic disease Dr Adam Fox United Kingdom Disclosures Lecture fees: Danone, Mead Johnson, ALK-Abello, Stallergenes, Allergy Therapeutics Industry-sponsored grant: Danone, ALK-Abello
More informationPerceived efficacy and satisfaction of patients with subcutaneous hypoallergenic high-dose house dust mite extract
O R I G I N A L A R T I C L E S Eur Ann Allergy Clin Immunol Vol 49, N 3, 0-5, 17 A. Roger Reig 1, M. Ibero Iborra 2, T. Carrillo Díaz 3, R. López Abad 4, V. Sánchez Moreno 5, J. Álvarez Nieto 6, N. Cancelliere
More informationSublingual Immunotherapy in Pediatric Patients: Beyond Clinical Efficacy
www.medscape.com To Print: Click your browser's PRINT button. NOTE: To view the article with Web enhancements, go to: http://www.medscape.com/viewarticle/501817 Sublingual Immunotherapy in Pediatric Patients:
More informationEar, Nose & Throat (ENT) - Head & Neck Surgery. Allergic Rhinitis (Sinus)
Ear, Nose & Throat (ENT) - Head & Neck Surgery Allergic Rhinitis (Sinus) The Department of Ear, Nose & Throat (ENT) - Head & Neck Surgery provides a wide range of surgical services for adult patients with
More informationHEALTH ECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY (AIT) FOR THE MANAGEMENT OF ALLERGIC RHINITIS, ASTHMA, FOOD ALLERGY AND VENOM ALLERGY
7 HEALTH ECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY (AIT) FOR THE MANAGEMENT OF ALLERGIC RHINITIS, ASTHMA, FOOD ALLERGY AND VENOM ALLERGY A SYSTEMATIC OVERVIEW Supplementary materials Miqdad Asaria 1,
More informationWest Houston Allergy & Asthma, P.A.
Consent to Receive Immunotherapy (ALLERGY SHOTS) Procedure Allergy injections are usually started at a very low dose. This dose is gradually increased on a regular (usually 1-2 times per week) basis until
More informationREFERRAL GUIDELINES - SUMMARY
Clinical Immunology & Allergy Unit LEEDS TEACHING HOSPITALS NHS TRUST REFERRAL GUIDELINES - SUMMARY THESE GUIDELINES ARE DESIGNED TO ENSURE THAT PATIENTS REQUIRING SECONDARY CARE ARE SEEN EFFICIENTLY AND
More informationAllergen Immunotherapy in Asthma: Now and in the Future
Allergen Immunotherapy in Asthma: Now and in the Future Young-Il Koh, M.D. Chonnam National University Medical School, Gwangju, Korea 2017-03-25 CHONNAM NATIONAL UNIVERSITY MEDICAL SCHOOL 1 Management
More informationDiscover the connection
Emma is worried about having a systemic reaction, so she avoids all nuts Walnuts FOOD ALLERGY Hazelnuts Peanuts Systemic reactions and underlying proteins Discover the connection ImmunoCAP Complete Allergens
More informationWORDS S UMMARY. R. Mösges, B. Ritter, G. Kayoko, D. Passali, S. Allekotte
Review Carbamylated monomeric allergoids... Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite and grass pollen induced allergic rhinoconjunctivitis: a
More informationOralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oralair Page: 1 of 5 Last Review Date: November 30, 2018 Oralair Description Oralair (Sweet Vernal,
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationThe Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis and Asthma
The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis and Asthma FACULTY Henry A. Wojtczak, MD Pediatric Pulmonologist Naval Medical Center San Diego, CA Dr. Wojtczak
More informationALK-Abelló Research & Development. Henrik Jacobi MD, EVP Research & Development
ALK-Abelló Research & Development Henrik Jacobi MD, EVP Research & Development Agenda Latest news on GRAZAX 3rd year data from long-term study (GT-08) Effect on asthma symptoms in children (GT-12) Status:
More informationClinical study of treatment of allergic asthma and allergic rhinitis using BICOM 2 Dr. Wang Jun, Dr. Lu Shu Jin, Tai an City, China OVERVIEW Clinical study using the BICOM 2 from March 24 to September
More informationAllergens: Science, Health Effects and Innovations
Allergens: Science, Health Effects and Innovations September 26 th -27 th 2017, Indoor Biotechnologies, Cardiff, UK Speaker profiles Matthew Perzanowski PhD Associate Professor Environmental Health Sciences
More informationScottish Medicines Consortium
Scottish Medicines Consortium Standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate (Grazax ) No. (367/07) ALK-Abellό Ltd 6 April 2007 The Scottish
More informationPresentation of ALK London, 24 May 2011 UBS GLOBAL SPECIALTY PHARMACEUTICALS CONFERENCE : LONDON : 24 MAY 2011
Presentation of ALK London, 24 May 2011 1 ALK pharma specialist - treatment, prevention and diagnosis of allergies World leader in allergy immunotherapy ~ 33% global market share Expanding Base Business
More informationFormulating hypotheses and implementing research in allergic disorders in rural Crete, Greece
Formulating hypotheses and implementing research in allergic disorders in rural Crete, Greece Christos Lionis and Leda Chatzi, Clinic of Social and Family Medicine, School of Medicine, University of Crete,
More informationFace to Face on LAIS Mechanism of action and clinical experiences
Kazan, 14-17 May 2014 Face to Face on LAIS Mechanism of action and clinical experiences Mario di Gioacchino Dept. of Medicine and Ageing Science University of Chieti. Italy Enrico Compalati Allergy & Respiratory
More informationSetting The setting was secondary care. The economic study was carried out in France.
Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France Omnes L F, Bousquet J, Scheinmann P, Neukirch F, Jasso-Mosqueda G,
More informationAllergies. Allergy. "Céad míle fáilte romhainn agus Lá. Fhéile Pádraig Sona Daoibh"
Allergies Why More Common? New Manifestations Management Options Dr. Robert Schellenberg, MD, FRCPC Dr. Amin Kanani, MD, FRCPC Dr. Donald Stark, MD, FRCPC "Céad míle fáilte romhainn agus Lá Fhéile Pádraig
More informationOVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON THE DEVELOPMENT OF PRODUCTS FOR SPECIFC IMMUNOTHERAY FOR THE TREATMENT OF ALLERGIC DISEASE
European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 23 June 2008 Doc. Ref. EMEA/CHMP/EWP/330620/2008 OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON THE DEVELOPMENT
More informationIMMUNOTHERAPY IN ALLERGIC RHINITIS
Rhinology research Chair Weekly Activity, King Saud University IMMUNOTHERAPY IN ALLERGIC RHINITIS E V I D E N C E D - B A S E O V E R V I E W O F T H E R U L E O F I M M U N O T H E R A P Y I N A L L E
More informationSensitivity to Sorghum Vulgare (Jowar) Pollens in Allergic Bronchial Asthma and Effect of Allergen Specific Immunotherapy
Indian J Allergy Asthma Immunol 2002; 16(1) : 41-45 Sensitivity to Sorghum Vulgare (Jowar) Pollens in Allergic Bronchial Asthma and Effect of Allergen Specific Immunotherapy Sanjay S. Pawar Shriratna Intensive
More informationCuring Allergy. Characteristics of products for specific allergy management. Jorgen Nedergaard Larsen, PhD. Senior scientist. dk.alk-abello.
Characteristics of products for specific allergy management Jorgen Nedergaard Larsen, PhD Senior scientist jnl @ dk.alk-abello.com 11 May 2012 Introduction to ALK-Abelló Pharmaceutical company devoted
More informationInformation and Consent for Administration of Immunotherapy (Allergy Injections)
Information and Consent for Administration of Immunotherapy (Allergy Injections) PLEASE READ AND BE CERTAIN THAT YOU UNDERSTAND THE FOLLOWING INFORMATION PRIOR TO SIGNING THIS CONSENT FOR TREATMENT PURPOSE
More informationSUMMARY OF PRODUCT CHARACTERISTICS. POLLINEX Grasses + Rye Extension Course, 2000 Standardised Units (SU)/0.5ml, suspension for injection
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT POLLINEX Grasses + Rye Extension Course, 2000 Standardised Units (SU)/0.5ml, suspension for injection 2. QUALITATIVE AND QUANTITATIVE
More informationGrastek. Grastek (timothy grass pollen allergen extract) Description. Section: Prescription Drugs Effective Date: January 1, 2018
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.07 Subject: Grastek Page: 1 of 5 Last Review Date: December 8, 2017 Grastek Description Grastek (timothy
More informationConcept paper on a Guideline for allergen products development in moderate to low-sized study populations
1 2 3 4 5 6 7 13 December 2018 EMA/CHMP/251023/2018 Rheumatology / Immunology Working Party (RIWP) Concept paper on a Guideline for allergen products development in moderate to low-sized study populations
More informationRagwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.05 Subject: Ragwitek Page: 1 of 5 Last Review Date: December 8, 2017 Ragwitek Description Ragwitek
More informationAllergy overload. Nip those springtime allergies in the bud
Y Name: VIBE ACTIVITIES E A R Issue 199 Years Healthy Vibe Healthy Body Allergy Overload page 26 Allergy overload Nip those springtime allergies in the bud W inter s over... the jumpers and trackies go
More informationAnti-IgE: beyond asthma
Anti-IgE: beyond asthma Yehia El-Gamal, MD, PhD, FAAAAI Professor of Pediatrics Pediatric Allergy and Immunology Unit Children s Hospital, Ain Shams University Member, WAO Board of Directors Disclosure
More informationUNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Basics of Pediatric Allergy Academic year 2015/2016 I. COURSE AIMS COURSE OUTLINE The specialty of allergy involves the management of a wide range
More informationRagwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.34 Subject: Ragwitek Page: 1 of 5 Last Review Date: December 3, 2015 Ragwitek Description Ragwitek
More informationNew Approaches to Immunotherapy: Beyond SCIT and SLIT
New Approaches to Immunotherapy: Beyond SCIT and SLIT Harold S. Nelson, MD Professor of Medicine National Jewish Health and University of Colorado Denver School of Medicine Denver, Colorado Disclosure:
More informationAccelerated Immunotherapy Schedules: More Convenient? Just As Safe?
Accelerated Immunotherapy Schedules: More Convenient? Just As Safe? David A. Khan, MD Professor of Medicine Allergy & Immunology Training Program Director Division of Allergy & Immunology University of
More informationNew Test ANNOUNCEMENT
March 2003 W New Test ANNOUNCEMENT A Mayo Reference Services Publication Pediatric Allergy Screen
More informationAEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS
AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 4, 2018 OBJECTIVES Review indications and evidence for aeroallergen immunotherapy
More informationThe Turkish Journal of Pediatrics 2018; 60: DOI: /turkjped
The Turkish Journal of Pediatrics 2018; 60: 50-55 DOI: 10.24953/turkjped.2018.01.007 Original Knowledge levels related to allergen specific immunotherapy and perspectives of parents whose children were
More informationWhat is allergy? Know your specific IgE
What is allergy? What is allergy? Know your specific IgE Allergies are very common and increasing in Australia and New Zealand, affecting around one in three people at some time in their lives. There are
More informationThe efficiency of immunotherapy to the subjects with allergy to bee venom and its influence in pollen allergy
The efficiency of immunotherapy to the subjects with allergy to bee venom and its influence in pollen allergy Abstract author: Dr. Leonora Hana Lleshi Certified specialist allergologist-immunologist ISA
More informationManaging and Treating Allergic Rhinitis in the Primary Care Setting
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2014 Managing and Treating Allergic Rhinitis in the Primary Care Setting Leah Novinger University
More informationWhy does the body develop allergies?
Allergies & Hay Fever Millions of Americans suffer from nasal allergies, commonly known as hay fever. Often fragrant flowers are blamed for the uncomfortable symptoms, yet they are rarely the cause; their
More informationCONTINUATION OF IMMUNOTHERAPY INJECTIONS AT RIDER UNIVERSITY ALLERGIST INFORMATION AND PERMISSION FORM
CONTINUATION OF IMMUNOTHERAPY INJECTIONS AT RIDER UNIVERSITY ALLERGIST INFORMATION AND PERMISSION FORM Dear Allergist: Your patient,, would like to continue allergy injections in our health center while
More informationPrecise results for safe decisions. How to better define and manage peanut allergy
Precise results for safe decisions How to better define and manage peanut allergy Better risk assessment with allergen components How can you differentiate between true peanut allergy or symptoms caused
More informationSLIT: Review and Update
SLIT: Review and Update Disclosure Speaker: ISTA Pharmaceuticals Speaker: GlaxoSmithKline Allergen IT - Evidence Based Evaluation: Rescue Medications Meta-analysis Disease IT # of Patients Rescue Medication
More informationMultiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis Vasco Bordignon, MD,* and Samuele E.
Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis Vasco Bordignon, MD,* and Samuele E. Burastero, MD Background: Sublingual immunotherapy (SLIT) is an
More informationAllergies & Hypersensitivies
Allergies & Hypersensitivies Type I Hypersensitivity: Immediate Hypersensitivity Mediated by IgE and mast cells Reactions: Allergic rhinitis (hay fever) Pollens (ragweed, trees, grasses), dust mite feces
More informationAllergic Rhinitis. What Does Allergic Rhinitis Mean? Published on: 9 Jul 2014
Published on: 9 Jul 2014 Allergic Rhinitis What Does Allergic Rhinitis Mean? Allergic rhinitis is the way doctors describe an allergy that affects the nose. What happens when you have an allergy? To understand
More informationScientific Contribution 2017
HAL Allergy Roadmap to Innovative and Registered Allergen Immunotherapy Registered Immunotherapy Phase III Phase II Pivotal Pre Clinical Phase I Dose Tolerability Dose Finding Scientific Contribution 27
More informationScientific Contribution 2018
Allergy in a changing world Scientific Contribution 218 37 th Congress of the European Academy of Allergy and Clinical Immunology EAACI, 26-3 - May 218, Munich, Germany Dear Congress delegate, On behalf
More informationOpinion Statement. Introduction. Allergic Rhinitis (M Calderon, Section Editor)
Curr Treat Options Allergy (2015) 2:32 38 DOI 10.1007/s40521-014-0039-4 Allergic Rhinitis (M Calderon, Section Editor) Safety and Efficacy of Allergen Immunotherapy in Patients with HIV and Allergic Rhinitis:
More informationProspective validation of the rhino conjunctivitis allergy-control-score (RC-ACS )
Häfner et al. Clinical and Translational Allergy 2012, 2:17 RESEARCH Open Access Prospective validation of the rhino conjunctivitis allergy-control-score (RC-ACS ) Dietrich Häfner 1*, Kristian Reich 2,
More informationCase History Number One. Case History Two. Selection and Preparation of Allergen Vaccines (Extracts) Single Allergen Associated With Allergic Disease
Selection and Preparation of Allergen Vaccines (Extracts) Richard F. Lockey, M.D. Division of Allergy and Immunology Department of Internal Medicine University of South Florida College of Medicine and
More informationAllergy, Asthma and the Athlete Sergio Bonini
Allergy, Asthma and the Athlete Sergio Bonini Professor of Medicine Second University of Naples Institute of Translational Pharmacology Italian National Research,Rome se.bonini@gmail.com Cancun December
More informationBronchial Hyperreactivity Is Related To Airflow Limitation And Independent Of Allergen Exposure In Hay Fever Patients
ISPUB.COM The Internet Journal of Asthma, Allergy and Immunology Volume 4 Number 1 Bronchial Hyperreactivity Is Related To Airflow Limitation And Independent Of Allergen Exposure In Hay Fever Patients
More informationAssociate Professor Rohan Ameratunga Immunologist & Allergist, Auckland
Associate Professor Rohan Ameratunga Immunologist & Allergist, Auckland Update on desensitisation Associate Professor Rohan Ameratunga GLORIA Module 4: Allergen Specific Immunotherapy A New Zealand perspective
More informationImproving allergy outcomes. Allergen Component Testing. Jay Weiss Ph.D and Gary Kitos, Ph.D. H.C.L.D.
Improving allergy outcomes Allergen Component Testing Jay Weiss Ph.D and Gary Kitos, Ph.D. H.C.L.D. Allergen Component Testing Allergic disease is an immunologic response to an allergen or allergens that
More informationSpeaking the Same Language: Grading System for Subcutaneous Immunotherapy Systemic Reaction World Allergy Organization Symposium Immunotherapy &
Speaking the Same Language: Grading System for Subcutaneous Immunotherapy Systemic Reaction World Allergy Organization Symposium Immunotherapy & Biologics 2012 Chicago Linda Cox, MD, FAAAAI Linda Cox,
More informationSublingual Immunotherapy as a Technique of Allergen Specific Therapy
Sublingual Immunotherapy as a Technique of Allergen Specific Therapy Policy Number: 2.01.17 Last Review: 7/2014 Origination: 7/2006 Next Review: 7/2015 Policy Blue Cross and Blue Shield of Kansas City
More information